Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ST-2427 / SiteOne Therap
NCT04475198: Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427	Terminated	1	24	US	ST-2427, Placebo	SiteOne Therapeutics, Inc., National Institute on Drug Abuse (NIDA)	Acute, Post-operative Pain	08/21	08/21
ST-Oral / SiteOne Therap
No trials found
ST-SubQ / SiteOne Therap
No trials found
ST-Topical / SiteOne Therap
No trials found
Voltage-gated sodium channels Nav 1.7 inhibitor / SiteOne Therap
No trials found
Voltage-gated sodium channels Nav 1.8 inhibitor / SiteOne Therap
No trials found